14.55USD-0.89%Mkt Cap: 646.61M USDP/E: —Last update: 2026-05-26
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It of…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
53.79BSEKP/E 100.1
52.47BSEKP/E 22.3
51.50BDKKP/E 21.8
50.54BUSDP/E 47.4
38.75BEURP/E 18.3
Indicators:|
Key Statistics
Company
Market Cap646.61M USD
Enterprise Value555.08M USD
Revenue (TTM)206.22M USD
Gross Profit159.88M USD
Net Income (TTM)-18.90M USD
Revenue/Share4.755 USD
Last Price14.55 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees376
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-41.97
PEG—
EV/EBITDA-40.12
EV/Revenue2.69
P/S3.18
P/B3.66
EPS (TTM)-0.39
EPS (Forward)-0.35
52W Range
11.4829% of range21.89
52W High21.89 USD
52W Low11.48 USD
Profitability
Gross Margin79.57%
Oper. Margin-9.69%
EBITDA Margin-6.71%
Profit Margin-9.41%
ROE-10.65%
ROA-7.92%
Growth
Revenue Growth11.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-675.00K USD
CapEx (TTM)8.41M USD
FCF Margin-1.29%
FCF Yield-0.41%
Net Debt-101.74M USD
Net Debt/EBITDA7.35
Balance Sheet
Debt/Equity0.21
Current Ratio9.99
Quick Ratio8.20
Book Value/Sh4.048 USD
Cash/Share3.262 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)23.33 USD
Target Range16.00 USD – 32.00 USD
# Analysts9
Ownership
Shares Out.44.35M
Float42.87M
Insiders3.28%
Institutions108.13%
Short Interest
Short Ratio7.0d
Short % Float11.98%
Short % Out.10.26%
Shares Short4.54M
Short (prev mo.)3.88M
Technical
SMA 5013.37 (+8.8%)
SMA 20015.81 (-8.0%)
Beta0.67
S&P 52W Chg28.31%
Avg Vol (30d)752.00K
Avg Vol (10d)1.16M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—